Melanoma inhibitory activity

Melanoma inhibitory activity
PDB rendering based on 1hjd.
Available structures PDB 1HJD, 1I1J, 1K0X
Identifiers
Symbols	MIA; CD-RAP
External IDs	OMIM: 601340 MGI: 109615 HomoloGene: 4763 GeneCards: MIA Gene
Gene Ontology Molecular function • protein binding • growth factor activity Cellular component • extracellular region • extracellular space Biological process • cell proliferation Sources: Amigo / QuickGO
Orthologs
Species	Human	Mouse
Entrez	8190	12587
Ensembl	ENSG00000213054	ENSMUSG00000089661
UniProt	Q16674	Q61865
RefSeq (mRNA)	NM_001202553.1	NM_019394.3
RefSeq (protein)	NP_001189482.1	NP_062267.2
Location (UCSC)	Chr 19: 41.28 – 41.28 Mb	Chr 7: 27.95 – 27.97 Mb
PubMed search	[1]	[2]

Melanoma-derived growth regulatory protein is a protein that in humans is encoded by the MIA gene.^[1][2][3]

It is a marker for malignant melanoma.^[4]

References

1. ^ Blesch A, Bosserhoff AK, Apfel R, Behl C, Hessdoerfer B, Schmitt A, Jachimczak P, Lottspeich F, Buettner R, Bogdahn U (Nov 1994). "Cloning of a novel malignant melanoma-derived growth-regulatory protein, MIA". Cancer Res 54 (21): 5695–701. PMID 7923218. 
2. ^ Koehler MR, Bosserhoff A, von Beust G, Bauer A, Blesch A, Buettner R, Schlegel J, Bogdahn U, Schmid M (Sep 1996). "Assignment of the human melanoma inhibitory activity gene (MIA) to 19q13.32-q13.33 by fluorescence in situ hybridization (FISH)". Genomics 35 (1): 265–7. doi:10.1006/geno.1996.0352. PMID 8661134. 
3. ^ "Entrez Gene: MIA melanoma inhibitory activity". http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=8190. 
4. ^ Bosserhoff AK, Kaufmann M, Kaluza B, et al. (August 1997). "Melanoma-inhibiting activity, a novel serum marker for progression of malignant melanoma". Cancer Res. 57 (15): 3149–53. PMID 9242442. http://cancerres.aacrjournals.org/cgi/pmidlookup?view=long&pmid=9242442. 

Further reading

• Bosserhoff AK, Hein R, Bogdahn U, Buettner R (1996). "Structure and promoter analysis of the gene encoding the human melanoma-inhibiting protein MIA.". J. Biol. Chem. 271 (1): 490–5. doi:10.1074/jbc.271.1.490. PMID 8550608. 
• Stoll R, Renner C, Zweckstetter M, et al. (2001). "The extracellular human melanoma inhibitory activity (MIA) protein adopts an SH3 domain-like fold.". Embo J. 20 (3): 340–9. doi:10.1093/emboj/20.3.340. PMID 11157741. 
• Lougheed JC, Holton JM, Alber T, et al. (2001). "Structure of melanoma inhibitory activity protein, a member of a recently identified family of secreted proteins.". Proc. Natl. Acad. Sci. U.S.A. 98 (10): 5515–20. doi:10.1073/pnas.091601698. PMID 11331761. 
• Lougheed JC, Domaille PJ, Handel TM (2002). "Solution structure and dynamics of melanoma inhibitory activity protein.". J. Biomol. NMR 22 (3): 211–23. doi:10.1023/A:1014961408029. PMID 11991352. 
• Hau P, Apfel R, Wiese P, et al. (2002). "Melanoma-inhibiting activity (MIA/CD-RAP) is expressed in a variety of malignant tumors of mainly neuroectodermal origin.". Anticancer Res. 22 (2A): 577–83. PMID 12014625. 
• Hau P, Wise P, Bosserhoff AK, et al. (2002). "Cloning and characterization of the expression pattern of a novel splice product MIA (splice) of malignant melanoma-derived growth-inhibiting activity (MIA/CD-RAP) [corrected].". J. Invest. Dermatol. 119 (3): 562–9. doi:10.1046/j.1523-1747.2002.00501.x. PMID 12230496. 
• Strausberg RL, Feingold EA, Grouse LH, et al. (2003). "Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.". Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. doi:10.1073/pnas.242603899. PMC 139241. PMID 12477932. http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=139241. 
• Poser I, Golob M, Buettner R, Bosserhoff AK (2003). "Upregulation of HMG1 leads to melanoma inhibitory activity expression in malignant melanoma cells and contributes to their malignancy phenotype.". Mol. Cell. Biol. 23 (8): 2991–8. doi:10.1128/MCB.23.8.2991-2998.2003. PMID 12665595. 
• Callejo SA, Marshall JC, Cools-Lartigue J, et al. (2005). "Macrophage-derived soluble factor enhances melanoma inhibitory activity expression by uveal melanoma cells in vitro.". Melanoma Res. 14 (2): 91–5. doi:10.1097/00008390-200404000-00003. PMID 15057037. 
• Marr DG, Poser I, Shellman YG, et al. (2005). "Ultraviolet radiation induces release of MIA: a new mechanism for UVR-induced progression of melanoma.". Int. J. Oncol. 25 (1): 105–11. PMID 15201995. 
• Poser I, Tatzel J, Kuphal S, Bosserhoff AK (2005). "Functional role of MIA in melanocytes and early development of melanoma.". Oncogene 23 (36): 6115–24. doi:10.1038/sj.onc.1207797. PMID 15208686. 
• Zhang Z, Henzel WJ (2005). "Signal peptide prediction based on analysis of experimentally verified cleavage sites.". Protein Sci. 13 (10): 2819–24. doi:10.1110/ps.04682504. PMC 2286551. PMID 15340161. http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=2286551. 
• Jachimczak P, Apfel R, Bosserhoff AK, et al. (2004). "Inhibition of immunosuppressive effects of melanoma-inhibiting activity (MIA) by antisense techniques.". Int. J. Cancer 113 (1): 88–92. doi:10.1002/ijc.20549. PMID 15386421. 
• Gerhard DS, Wagner L, Feingold EA, et al. (2004). "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).". Genome Res. 14 (10B): 2121–7. doi:10.1101/gr.2596504. PMC 528928. PMID 15489334. http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=528928. 
• Hau P, Ruemmele P, Kunz-Schughart LA, et al. (2005). "Expression levels of melanoma inhibitory activity correlate with time to progression in patients with high-grade glioma.". Oncol. Rep. 12 (6): 1355–64. PMID 15547763. 
• Tatzel J, Poser I, Schroeder J, Bosserhoff AK (2005). "Inhibition of melanoma inhibitory activity (MIA) expression in melanoma cells leads to molecular and phenotypic changes.". Pigment Cell Res. 18 (2): 92–101. doi:10.1111/j.1600-0749.2005.00212.x. PMID 15760338. 
• Aung PP, Oue N, Mitani Y, et al. (2006). "Systematic search for gastric cancer-specific genes based on SAGE data: melanoma inhibitory activity and matrix metalloproteinase-10 are novel prognostic factors in patients with gastric cancer.". Oncogene 25 (17): 2546–57. doi:10.1038/sj.onc.1209279. PMID 16331256. 
• Cao MG, Auge JM, Molina R, et al. (2007). "Melanoma inhibiting activity protein (MIA), beta-2 microglobulin and lactate dehydrogenase (LDH) in metastatic melanoma.". Anticancer Res. 27 (1B): 595–9. PMID 17348447. 

v · d · ePDB gallery 1hjd: MELANOMA INHIBITORY ACTIVITY (MIA) PROTEIN   1i1j: STRUCTURE OF MELANOMA INHIBITORY ACTIVITY PROTEIN: A MEMBER OF A NEW FAMILY OF SECRETED PROTEINS   1k0x: Solution Structure of Melanoma Inhibitory Activity Protein

v · d · eTumor markers Blood Lymphoma Neprilysin Lymphosarcoma CD3 · CD79a Endocrine Thyroid cancer Thyroglobulin · Medullary thyroid cancer (Calcitonin, Carcinoembryonic antigen) Pheochromocytoma Normetanephrine · Enolase 2 Neuroendocrine tumors Synaptophysin · Chromogranin A Neuroblastoma Homovanillic acid Nervous system Brain tumor PCNA Astrocytoma Glial fibrillary acidic protein NC/Melanoma S-100 protein · Melanoma inhibitory activity Cardiovascular/ respiratory Lung cancer Carcinoembryonic antigen · Enolase 2 · Autocrine motility factor Hemangiosarcoma (endothelium) Factor VIII Digestive Colorectal cancer CA19-9 · Carcinoembryonic antigen Pancreatic cancer CA19-9 · Carcinoembryonic antigen · CA 242 · Tumor-associated glycoprotein 72 Hepatocellular carcinoma Alpha-fetoprotein/AFP-L3 Reproductive/ urinary/ breast Ovarian tumor Surface epithelial-stromal tumor (CA-125) · EC (CD30, hCG) · EST (Alpha-fetoprotein) · Choriocarcinoma (hCG) · Dysgerminoma (LDH) · Sertoli-Leydig cell tumour (Testosterone) · GCT (Inhibin) Testicular cancer βhCG · Alpha-fetoprotein/AFP-L3 · CD30 Prostate cancer Prostate specific antigen · Prostatic acid phosphatase · Glutamate carboxypeptidase II · erbB-3 receptor · Early prostate cancer antigen-2 · SPINK1 · GOLPH2 · PCA3 · TMPRSS2 Germ cell tumor NANOG Bladder cancer erbB-3 receptor · NMP22 Breast cancer CA 15-3 · erbB-2 receptor · erbB-3 receptor · Cathepsin D General histology Sarcoma Vimentin Carcinoma (epithelium) Cytokeratin Musculoskeletal Rhabdomyosarcoma Desmin M: NEO tsoc, mrkr tumr, epon, para drug (L1i/1e/V03)

This protein-related article is a stub. You can help Wikipedia by expanding it.v · d · e

This entry is from Wikipedia, the leading user-contributed encyclopedia. It may not have been reviewed by professional editors (see full disclaimer)